The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Cardioquip sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Cardioquip is a dynamic medical technology company specializing in the design, development, and distribution of innovative patient temperature control devices for cardiovascular perfusionists. The company offers MCH-1000 the leading cooler-heater that has a next-generation touchscreen interface. It also offers a diverse range of related products and services, including a cardiopulmonary blanket connection module, refrigeration module, communications module, dripless hose set, and other critical care equipment. It also offers technical support, preventive maintenance, and other services. The company offers its products in the US and Europe. CardioQuip is headquartered in College Station, Texas, the US.
The key metrics of Cardioquip related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Cardioquip is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Cardioquip.
For a detailed understanding of the performance of Cardioquip, buy the report here.